A Naturally Generated Decoy of the Prostate Apoptosis Response-4 Protein Overcomes Therapy Resistance in Tumors
Open Access
- 1 August 2017
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 77 (15) , 4039-4050
Abstract
Primary tumors are often heterogeneous, composed of therapy-sensitive and emerging therapy-resistant cancer cells. Interestingly, treatment of therapy-sensitive tumors in heterogeneous tumor microenvironments results in apoptosis of therapy-resistant tumors. In this study, we identify a prostate apoptosis response-4 (Par-4) amino-terminal fragment (PAF) that is released by diverse therapy-sensitive cancer cells following therapy-induced caspase cleavage of the tumor suppressor Par-4 protein. PAF caused apoptosis in cancer cells resistant to therapy and inhibited tumor growth. A VASA segment of Par-4 mediated its binding and degradation by the ubiquitin ligase Fbxo45, resulting in loss of Par-4 proapoptotic function. Conversely, PAF, which contains this VASA segment, competitively bound to Fbxo45 and rescued Par-4–mediated induction of cancer cell–specific apoptosis. Collectively, our findings identify a molecular decoy naturally generated during apoptosis that inhibits a ubiquitin ligase to overcome therapy resistance in tumors. Cancer Res; 77(15); 4039–50. ©2017 AACR.Keywords
All Related Versions
Funding Information
- NIH (R01CA187273, R01CA165469, and R21CA179283)
This publication has 38 references indexed in Scilit:
- Arylquins target vimentin to trigger Par-4 secretion for tumor cell apoptosisNature Chemical Biology, 2014
- Caspase-8-mediated PAR-4 cleavage is required for TNFα-induced apoptosisOncotarget, 2014
- Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activityProceedings of the National Academy of Sciences, 2008
- Inactivation of the Candidate Tumor Suppressor Par-4 in Endometrial CancerCancer Research, 2007
- Binding and Phosphorylation of Par-4 by Akt Is Essential for Cancer Cell SurvivalMolecular Cell, 2005
- Tumour‐suppression activity of the proapoptotic regulator Par4EMBO Reports, 2005
- Identification of a Unique Core Domain of Par-4 Sufficient for Selective Apoptosis Induction in Cancer CellsMolecular and Cellular Biology, 2003
- Antiandrogen-induced cell death in LNCaP human prostate cancer cellsCell Death & Differentiation, 2003
- Apoptosis by Par-4 in cancer and neurodegenerative diseasesExperimental Cell Research, 2003
- TRAIL Receptors 1 (DR4) and 2 (DR5) Signal FADD-Dependent Apoptosis and Activate NF-κBImmunity, 1997